
MULTIR
MULti-Tumour based prediction and manipulation of Immune Response
Combining multi-layer cancer data and AI to improve the prediction and personalisation of therapy response.
View project↗
A selected portfolio of funded European research and innovation projects.
Our team has contributed to complex international projects across health, advanced technologies and researcher training—connecting strong proposals with disciplined implementation, communication, exploitation and impact.
Filter by framework or area of experience.

Combining multi-layer cancer data and AI to improve the prediction and personalisation of therapy response.
View project↗
Integrating epidemiological, clinical and experimental data to understand progression to active multiple myeloma.
View project↗
Developing scalable extracellular-vesicle purification for cancer diagnostics and therapeutic delivery.
View project↗
Advancing clean, selective and scalable integration of two-dimensional materials for photonic applications.
View project↗
Investigating the shared mechanisms connecting cardiovascular disease and depression.
View project↗
Creating an international harmonised cohort and data platform to address clinical and health-policy needs in primary Sjögren’s Syndrome.
View project↗
Developing laser-based nano-manufacturing for the controlled transfer and engineering of two-dimensional materials.
View project↗
Developing label-free endoscopic imaging methods for early cancer detection and assessment of tumour-prone tissue.
View project↗
Training researchers and applying systems medicine to understand chronic kidney disease.
View project↗
Training young researchers while advancing a drug-coated balloon system for improved treatment of peripheral artery disease.
View project↗
Exploring microbiome- and phage-based approaches to restore airway eubiosis in asthma.
View project↗
Training a new generation of researchers to reduce cardiovascular burden in chronic kidney disease.
View project↗Selected portfolio based on the supplied grant agreements. Project names and logos remain the property of their respective consortia.